Drug
Adu S100
Adu S100: highest development phase Phase 2, developed by Chinook Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Chinook Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| ADU-S100 NCT03937141 | Phase 2 | Metastatic Head and Neck Cancer |
| ADU-S100 NCT02675439 | Phase 1 | Advanced/Metastatic Solid Tumors or Lymphomas |
Latest
No recent events.
Follow Adu S100 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.